Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,075Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-401.9EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)20.2Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.2PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M26,200,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IBB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
IBBGeorge Soros 2016-06-30 Sold Out -0.49%$241.49 - $288.34
$ 270.040%Sold Out0
IBBGeorge Soros 2016-03-31 Buy 0.49%$244.04 - $338.33
$ 270.040%New holding67,600
IBBKeeley Asset Management Corp 2015-09-30 Sold Out -0.01%$289.48 - $398
$ 270.04-25%Sold Out0
IBBGeorge Soros 2015-09-30 Sold Out -0.01%$289.48 - $398
$ 270.04-25%Sold Out0
IBBGeorge Soros 2015-06-30 Buy 0.01%$333.61 - $383.19
$ 270.04-25%New holding2,400
IBBKeeley Asset Management Corp 2014-12-31 Buy 0.01%$255.27 - $308.01
$ 270.04-5%New holding905
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IBB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

IBB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BEST, SIMON GEOFFREYDirector 2016-10-07Buy2,750$2.939116.38view
Camilli, Kathleen MaryDirector 2016-10-07Buy5,000$4.995311.62view
Breault, Robert PaulDirector 2016-10-07Sell68,500$0.7137933.8view
Meade, Harlan DonnleyDirector, Senior Officer 2016-10-07Buy3,000$0.16168675view
Lemasson, ClaudeDirector, Senior Officer 2016-10-07Buy100,000$0.833655view
ESTEPA, JORGEDirector or Senior Officer of 10% Security Holder, 2016-10-07Buy3,500$0.467410view
Griffiths, Richard Ian10% Security Holder 2016-10-07Buy89,500$067410view
Hinchcliffe, Robert10% Security Holder, Director, Senior Officer 2016-10-07Buy3,500$0.4461272.73view
Reeson, DouglasDirector, Senior Officer 2016-10-07Buy15,000$0.08337450view
Anderson, Christopher RossDirector 2016-10-07Buy28,000$0.14192785.71view

Press Releases about IBB :

Quarterly/Annual Reports about IBB:

    News about IBB:

    Articles On GuruFocus.com
    Investment Strategies for the Bullish Biotech Sector Jun 01 2015 

    More From Other Websites
    Bio-Tech; In more trouble if this fails, says Joe Friday Oct 21 2016
    Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech Oct 20 2016
    Trending on ETFdb.com: Samsung Electronics Hurt by Galaxy Note 7 Recall Crisis Oct 20 2016
    Stocks close higher after strong Goldman, Netflix earnings Oct 18 2016
    361 Capital Weekly Research Briefing: Confused? Oct 18 2016
    Stocks close lower as consumer discretionary lags; Fed, earnings in focus Oct 17 2016
    California's drug pricing bill Oct 17 2016
    Parker: US equity market relatively good investment Oct 17 2016
    Watch for buying if the S&P falls to this level Oct 17 2016
    Can Biotech Stocks Stay “Trendy”? Oct 14 2016
    The politics of health care Oct 12 2016
    The stock market’s ugly Tuesday nosedive can be explained in one chart Oct 12 2016
    U.S. stocks slump most in nearly a month on Alcoa’s results, firm dollar Oct 11 2016
    Supernus Stock Reverses Downward Despite Good ADHD Drug Trial Oct 11 2016
    Illumina Stock Crashes On Troubling Outlook, Sales Miss Oct 11 2016
    Pisani: Oil is one excuse for market pullback Oct 11 2016
    Prepare for a Clinton Presidency with These Stocks & ETFs Oct 11 2016
    Beneath a Placid Stock Market, Much is Riding on Financial Stocks Oct 10 2016
    Mylan soars on EpiPen settlement Oct 10 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)